Core Viewpoint - Molina's quarterly earnings of 5.05persharefellshortoftheZacksConsensusEstimateof5.81 per share, marking an earnings surprise of -13.08% [1] - The company reported revenues of 10.5billionforthequarter,slightlymissingtheconsensusestimateby0.049.05 billion year-over-year [2] Financial Performance - Earnings per share (EPS) for the same quarter last year was 4.38,indicatingayear−over−yearincrease[1]−Overthelastfourquarters,MolinahassurpassedconsensusEPSestimatesthreetimes[2]−ThecurrentconsensusEPSestimatefortheupcomingquarteris6.60, with expected revenues of 10.71billion,andforthecurrentfiscalyear,theEPSestimateis26.06 on revenues of $43.78 billion [7] Market Performance - Molina shares have increased approximately 8.4% since the beginning of the year, outperforming the S&P 500's gain of 2.7% [3] - The company's stock currently holds a Zacks Rank 4 (Sell), indicating expectations of underperformance in the near future [6] Industry Outlook - The Medical - HMOs industry, to which Molina belongs, is currently ranked in the bottom 8% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Molina's stock performance [5]